Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Moderna (MRNA) Tops Q2 EPS by 6c, Beats on Revenue
July 31, 2026 7:01 AM EDTModerna (NASDAQ: MRNA) reported Q2 EPS of ($1.97), $0.06 better than the analyst estimate of ($2.03). Revenue for the quarter came in at $100 million versus the consensus estimate of $99.91 million.
For earnings history and earnings-related data on Moderna (MRNA) click here.
... More


